Search - Prime Therapeutics
Navigate to
-
BioSpace: While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that myriad variables are causing patients to stop treatment
PA Sub-Categories: GLP-1 Prime Article: In the News -
Managed Healthcare Executive: A Prime Therapeutics analysis of real-world data has found that medical costs for patients taking GLP-1 drugs for obesity had increased by about $1,338 per member,...
PA Sub-Categories: GLP-1 Prime Article: In the News -
Forbes
PA Sub-Categories: GLP-1 Prime Article: In the News -
Pharmacy Practice News, originally published by Specialty Pharmacy Continuum
PA Sub-Categories: GLP-1 Prime Article: In the News -
BioSpace: As obesity drug developers compete for the highest weight-loss efficacy, experts contend that overall health outcomes—evidenced by successful studies in therapeutic areas like...
PA Sub-Categories: GLP-1 Prime Article: In the News -
Specialty Pharmacy Continuum
PA Sub-Categories: GLP-1 Prime Article: In the News -
Managed Healthcare Executive
PA Sub-Categories: GLP-1 Prime Article: In the News -
Academy of Managed Care Pharmacy (AMCP)
PA Sub-Categories: GLP-1 Prime Article: In the News -
BioPharma Dive: There are no drugs specifically for polycystic ovary syndrome, a chronic condition that can cause infertility. One study is testing whether Wegovy might be beneficial.
PA Sub-Categories: GLP-1 Prime Article: In the News -
Star Tribune
PA Sub-Categories: GLP-1 Prime Article: In the News -
The American Journal of Managed Care (AJMC): The growing list of insurers dropping coverage for costly GLP-1 weight loss drugs leaves patients to bear even higher out-of-pocket expenses while still...
PA Sub-Categories: GLP-1 Prime Article: In the News -
Managed Healthcare Executive: Use of GLP-1 drugs and weight-loss care management programs need to focus on adherence and persistency for better health outcomes, suggests Prime...
PA Sub-Categories: GLP-1 Prime Article: In the News -
CNN: At 37:03, listen to fitness expert Jillian Michaels cite Prime/Magellan Rx research on a podcast recording of a June 21 CNN broadcast
PA Sub-Categories: GLP-1 Prime Article: In the News -
Forbes
PA Sub-Categories: GLP-1 Prime Article: In the News -
U.S. News & World Report
PA Sub-Categories: GLP-1 Prime Article: In the News -
Forbes
PA Sub-Categories: GLP-1 Prime Article: In the News -
Journal of Managed Care & Specialty Pharmacy (JMCP)
PA Sub-Categories: GLP-1 Prime Article: In the News -
Managed Healthcare Executive
PA Sub-Categories: Specialty drugs Prime Article: In the News -
Managed Healthcare Executive
PA Sub-Categories: GLP-1 Prime Article: In the News -
USA Today
PA Sub-Categories: GLP-1 Prime Article: In the News -
Reuters
PA Sub-Categories: GLP-1 Prime Article: In the News -
Insider
PA Sub-Categories: GLP-1 Prime Article: In the News -
CNBC
PA Sub-Categories: GLP-1 Prime Article: In the News -
Formulary Watch
PA Sub-Categories: GLP-1 Prime Article: In the News -
Star Tribune
PA Sub-Categories: GLP-1 Prime Article: In the News -
Business Insider
PA Sub-Categories: GLP-1 Prime Article: In the News -
Endpoint News
PA Sub-Categories: GLP-1 Prime Article: In the News -
Reuters
PA Sub-Categories: GLP-1 Prime Article: In the News -
Washington Post: Doctors and patients struggle with starting and stopping medications with little guidance.
PA Sub-Categories: GLP-1 Prime Article: In the News -
Reuters
PA Sub-Categories: GLP-1 Prime Article: In the News -
Reuters
PA Sub-Categories: GLP-1 Prime Article: In the News -
NBC News: Patients weren't asked why they quit taking the weight loss drugs
PA Sub-Categories: GLP-1 Prime Article: In the News -
Managed Markets Insight & Technology (MMIT)
PA Sub-Categories: Specialty drugs Products Prime Article: In the News -
Pharmacy Times
PA Sub-Categories: Specialty drugs Prime Article: In the News -
Becker’s Payer Issues
PA Sub-Categories: Specialty drugs Prime Article: In the News -
The American Journal of Managed Care (AJMC): At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection,...
PA Sub-Categories: Awards Prime Article: In the News -
Specialty Pharmacy Continuum
PA Sub-Categories: Specialty drugs Prime Article: In the News -
Reprinted with AIS Health permission from the November 2024 issue of Radar on Specialty Pharmacy
PA Sub-Categories: Specialty drugs Prime Article: In the News -
AIS Health
PA Sub-Categories: Specialty drugs Prime Article: In the News -
Managed Healthcare Executive
PA Sub-Categories: Specialty drugs Prime Article: In the News